These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9054617)

  • 1. Genetic alterations in N-bis(2-hydroxypropyl)nitrosamine-induced rat transplantable thyroid carcinoma lines: analysis of the TSH-R, G(alpha)s, ras and p53 genes.
    Kitahori Y; Naitoh H; Konishi N; Ohnishi T; Hiasa Y
    Carcinogenesis; 1997 Feb; 18(2):265-9. PubMed ID: 9054617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G --> A mutation of ras genes and infrequent p53 gene mutation in rat transplantable thyroid carcinoma lines from tumors induced in vivo by N-bis(2-hydroxypropyl)nitrosamine.
    Kitahori Y; Naitoh H; Konishi N; Fukushima M; Ohnishi T; Hiasa Y
    Cancer Lett; 1996 Feb; 100(1-2):55-62. PubMed ID: 8620454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent mutations of Ki-ras codon 12 in N-bis (2-hydroxypropyl)-nitrosamine-initiated thyroid, kidney and lung tumors in Wistar rats.
    Kitahori Y; Naito H; Konishi N; Ohnishi T; Shirai T; Hiasa Y
    Cancer Lett; 1995 Sep; 96(2):155-61. PubMed ID: 7585451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-ras oncogene activation in transplantable rat thyroid carcinoma induced by N-bis(2-hydroxypropyl)nitrosamine.
    Hiasa Y; Kitahori Y; Nakahashi K; Yane K; Konishi N; Lin JC; Okaichi K; Ohnishi T
    Cancer Lett; 1994 Aug; 83(1-2):209-14. PubMed ID: 8062217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms.
    Matsuo K; Friedman E; Gejman PV; Fagin JA
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1446-51. PubMed ID: 8501149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations in thyroid hyperfunctioning adenomas.
    Russo D; Arturi F; Wicker R; Chazenbalk GD; Schlumberger M; DuVillard JA; Caillou B; Monier R; Rapoport B; Filetti S
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1347-51. PubMed ID: 7714109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of the stimulatory G protein alpha-subunit mutations in autonomously functioning thyroid adenomas in Japan.
    Tanaka K; Nagayama Y; Takeshita A; Namba H; Yamashita S; Niwa M; Nagataki S
    Thyroid; 1996 Jun; 6(3):195-9. PubMed ID: 8837326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
    Russo D; Arturi F; Schlumberger M; Caillou B; Monier R; Filetti S; Suárez HG
    Oncogene; 1995 Nov; 11(9):1907-11. PubMed ID: 7478621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations in HCA-induced tumors.
    Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
    Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
    Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
    Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas.
    Chang KW; Lin SC; Koos S; Pather K; Solt D
    Carcinogenesis; 1996 Mar; 17(3):595-600. PubMed ID: 8631150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines.
    Erill N; Cuatrecasas M; Sancho FJ; Farré A; Pour PM; Lluís F; Capellá G
    Am J Pathol; 1996 Oct; 149(4):1333-9. PubMed ID: 8863680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes.
    Niepomniszcze H; Suárez H; Pitoia F; Pignatta A; Danilowicz K; Manavela M; Elsner B; Bruno OD
    Thyroid; 2006 May; 16(5):497-503. PubMed ID: 16756473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
    Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
    J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation.
    Spambalg D; Sharifi N; Elisei R; Gross JL; Medeiros-Neto G; Fagin JA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3898-901. PubMed ID: 8923835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas.
    Derwahl M; Hamacher C; Russo D; Broecker M; Manole D; Schatz H; Kopp P; Filetti S
    J Clin Endocrinol Metab; 1996 May; 81(5):1898-904. PubMed ID: 8626855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low frequency of p53 mutations in human thyroid tumours; p53 and Ras mutation in two out of fifty-six thyroid tumours.
    Salvatore D; Celetti A; Fabien N; Paulin C; Martelli ML; Battaglia C; Califano D; Monaco C; Viglietto G; Santoro M; Fusco A
    Eur J Endocrinol; 1996 Feb; 134(2):177-83. PubMed ID: 8630516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas.
    Russo D; Arturi F; Suarez HG; Schlumberger M; Du Villard JA; Crocetti U; Filetti S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1548-51. PubMed ID: 8636365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
    Fagin JA; Matsuo K; Karmakar A; Chen DL; Tang SH; Koeffler HP
    J Clin Invest; 1993 Jan; 91(1):179-84. PubMed ID: 8423216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
    Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG
    Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.